Ralf Clemens
Director/Board Member at CLOVER BIOPHARMACEUTICALS, LTD.
Net worth: 30 324 $ as of 2024-04-29
Network origin in Ralf Clemens first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
18
| Subsidiary | Biotechnology | 18 |
| Public Company | Pharmaceuticals: Major | 18 | |
10
| Public Company | Biotechnology | 10 |
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Novartis Vaccines & Diagnostics Srl
1
| Extinct | 1 | |
African Research Excellence Fund
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ralf Clemens via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal General Counsel | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Chief Executive Officer Corporate Officer/Principal | |
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Graduate Degree Undergraduate Degree | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Founder President | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member |
Statistics
International
| United States | 21 |
| Germany | 10 |
| Belgium | 8 |
| Austria | 3 |
| Denmark | 3 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 382 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 85 |
| Chairman | 84 |
| Chief Executive Officer | 69 |
Most connected contacts
| Insiders | |
|---|---|
| George Bickerstaff | 37 |
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Hans Lennart Rudolf Wigzell | 30 |
| David Lawrence | 29 |
| Michel Gréco | 28 |
| Hing Ling Chau | 25 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Frank Morich | 21 |
| Bali Muralidhar | 20 |
| Deborah Dunsire | 19 |
| Mathias Hothum | 19 |
| Michael Vasconcelles | 17 |
| Lindiwe Majele Sibanda | 17 |
- Stock Market
- Insiders
- Ralf Clemens
- Company connections